(Total Views: 568)
Posted On: 06/13/2022 11:59:00 PM
Post# of 154089
Dr. Ashok Dutta of Avisol relays his investing style in this podcast. Very conservative, simplistic and tilted towards big pharma.
He did like Intercept Pharmaceuticals for NASH in August 2019 when it was around $111, now it's $11.95. Intercept Pharmaceuticals has a drug called Obeticholic Acid that failed in NASH.
He liked ODT (now ODTC) that was at $43 saying it had upside. It is currently at $1.45.
https://podtail.com/en/podcast/marketplace-ro...ting-with/
He did like Intercept Pharmaceuticals for NASH in August 2019 when it was around $111, now it's $11.95. Intercept Pharmaceuticals has a drug called Obeticholic Acid that failed in NASH.
He liked ODT (now ODTC) that was at $43 saying it had upside. It is currently at $1.45.
https://podtail.com/en/podcast/marketplace-ro...ting-with/
(11)
(1)
